Physician profile
Thomas J Dingle
NPI 1073694915
$2,522.64
in general payments reported to CMS, 2019-2025
18 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,234 · 2020: $151 · 2021: $150 · 2022: $287 · 2023: $228 · 2024: $297 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.29 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $936.59 | 2019 | |
| Alcon Vision LLC | $357.71 | 2019-2025 | Clareon, Argos, Rocklatan |
| Biotissue Holdings INC. | $257.64 | 2020-2024 | |
| Kala Pharmaceuticals, INC. | $237.72 | 2019-2022 | |
| Abbvie INC. | $142.87 | 2022-2025 | Lumigan |
| Novartis Pharmaceuticals Corporation | $115.13 | 2019-2023 | |
| Oyster Point Pharma, INC. | $95.25 | 2022-2024 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $75.74 | 2022-2023 | Miebo, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $53.05 | 2019 | |
| Sun Pharmaceutical Industries INC. | $52.77 | 2022-2023 | Cequa |
| Tarsus Pharmaceuticals, INC. | $34.19 | 2024 | Xdemvy |
| Allergan, INC. | $32.89 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $32.50 | 2024 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Dompe US, INC. | $28.32 | 2020 | |
| Harrow Eye, LLC | $20.10 | 2025 | Triesence |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Shire North American Group INC | $18.21 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Dingle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.